Citi gets Irish biotech ADR mandate
07 February 2012 London
Image: Shutterstock
Citi Global Transaction Services (GTS) has announced its appointment by Elan Corporation as successor depositary bank for its American Depositary Receipt (ADR) programme.
Elan's shares trade on the Irish Stock Exchange and the biotechnology company's ADRs trade on the New York Stock Exchange, one ADR represents one ordinary share.
Dirk Jones, global head of Securities and Fund Services Client Sales Management at Citi, said, "We are pleased that Elan has chosen Citi as successor depositary bank for their ADR programme. By leveraging our global distribution network and liquidity management services, we're confident we can deliver the resources required to ensure the success of Elan's programme."
Elan's shares trade on the Irish Stock Exchange and the biotechnology company's ADRs trade on the New York Stock Exchange, one ADR represents one ordinary share.
Dirk Jones, global head of Securities and Fund Services Client Sales Management at Citi, said, "We are pleased that Elan has chosen Citi as successor depositary bank for their ADR programme. By leveraging our global distribution network and liquidity management services, we're confident we can deliver the resources required to ensure the success of Elan's programme."
NO FEE, NO RISK
100% ON RETURNS If you invest in only one asset servicing news source this year, make sure it is your free subscription to Asset Servicing Times
100% ON RETURNS If you invest in only one asset servicing news source this year, make sure it is your free subscription to Asset Servicing Times
